Alcami Corporation

Alcami Corporation

Alcami's website states it operates in the United States, with a headquarters in North Carolina. The firm describes 45-plus years of experience advancing pharmaceuticals and biologics from development to delivery. Ownership is held by a consortium of private equity firms: GHO Capital, The Vistria Group, and Ampersand Capital Partners. The firm brands its integrated offering as spanning lab services, drug product manufacturing, and cGMP-compliant pharma storage with support services. The contract development and manufacturing organization's model combines analytical testing and development services with finished-dose form manufacturing. The firm explicitly names oral solid dose and sterile fill-finish capabilities on its site. Downstream, Alcami's cGMP storage network offers ambient, refrigerated, and frozen conditions alongside environmental monitoring and validation. The geographic footprint is domestic, with the firm's only disclosed site in Wilmington, North Carolina. No team size, named executives, or specific financial metrics are disclosed. The three named private equity sponsors — GHO Capital, The Vistria Group, and Ampersand Capital Partners — collectively govern the asset, a structure common in healthcare services buyouts. Location data is limited to the contact page's single North Carolina reference. Alcami's structural differentiator is its tripartite private equity consortium ownership, a governance arrangement seen in buy-and-build pharmaceutical services platforms. The consortium structure can influence capital allocation and eventual exit strategies relative to single-sponsor CDMO peers.